Entinostat Plus Pembrolizumab Shows Promise in Previously Treated Melanoma

April 4, 2019
Ryan J. Sullivan, MD

Cancer Network spoke with Ryan J. Sullivan, MD, about the efficacy and safety of entinostat plus pembrolizumab in patients previously treated with immunotherapy.

Cancer Network spoke with Ryan J. Sullivan, MD, about the efficacy and safety of entinostat plus pembrolizumab in patients previously treated with immunotherapy.